Skip to main content
Log in

Secretion of biologically active human interleukin 22 (IL-22) by Lactococcus lactis

  • Original Research Paper
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

Interleukin-22 (IL-22) participates in the modulation of innate immunity and inflammation. This cytokine has important therapeutic potential, such as with ulcerative colitis, liver and lung injury, and infection, in different animal models. We generated a Lactococcus lactis strain that secretes human IL-22 under the regulation of the nisin-inducible promoter. Identification and secretion of this cytokine was demonstrated using western blots of culture supernatants from IL-22-expressing bacteria. The recombinant IL-22 protein produced by L. lactis was biologically active as determined by its ability to induce IL-10 secretion when co-cultured with a colon epithelial cell line in vitro. We consider this novel strain a promising live vaccine for various therapeutic applications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Braat H, Rottiers P, Hommes DW et al (2006) A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 4:754–759

    CAS  Google Scholar 

  • Dong H, Rowland I, Yaqoob P (2012) Comparative effects of six probiotic strains on immune function in vitro. Br J Nutr 108:459–470

    Article  PubMed  CAS  Google Scholar 

  • Haller D, Blum S, Bode C et al (2000) Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect Immun 68:752–759

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Holo H, Nes IF (1989) High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl Environ Microbiol 55:3119–3123

    PubMed  CAS  PubMed Central  Google Scholar 

  • Kuipers OP, de Ruyter PG, Kleerebezem M, de Vos WM (1997) Controlled overproduction of proteins by lactic acid bacteria. Trends Biotechnol 15:135–140

    Article  PubMed  CAS  Google Scholar 

  • Mierau I, Kleerebezem M (2005) 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol 68:705–717

    Article  PubMed  CAS  Google Scholar 

  • Mühl H, Scheiermann P, Bachmann M et al (2013) IL-22 in tissue-protective therapy. Br J Pharmacol 169:761–771

    Article  PubMed  PubMed Central  Google Scholar 

  • Nagalakshmi ML, Rascle A, Zurawski S et al (2004) Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int Immunopharmacol 4:679–691

    Article  PubMed  CAS  Google Scholar 

  • Simonian PL, Wehrmann F, Roark CL et al (2010) γδ T cells protect against lung fibrosis via IL-22. J Exp Med 207:2239–2253

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Sonnenberg GF, Fouser LA, Artis D (2011) Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 12:383–390

    Article  PubMed  CAS  Google Scholar 

  • Steidler L (2002) In situ delivery of cytokines by genetically engineered Lactococcus lactis. Antonie Van Leeuwenhoek 82:323–331

    Article  PubMed  CAS  Google Scholar 

  • Steidler L, Hans W, Schotte L et al (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289:1352–1355

    Article  PubMed  CAS  Google Scholar 

  • Sugimoto K, Ogawa A, Mizoguchi E et al (2008) IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118:534–544

    PubMed  CAS  PubMed Central  Google Scholar 

  • Villatoro-Hernandez J, Loera-Arias MJ, Gamez-Escobedo A et al (2008) Secretion of biologically active interferon-gamma inducible protein-10 (IP-10) by Lactococcus lactis. Microb Cell Fact 7:22

    Article  PubMed  PubMed Central  Google Scholar 

  • Villatoro-Hernández J, Kuipers OP, Saucedo-Cárdenas O, Montes-de-Oca-Luna R (2012) Heterologous protein expression by Lactococcus lactis. Methods Mol Biol Clifton NJ 824:155–165

    Article  Google Scholar 

  • Wells JM, Mercenier A (2008) Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 6:349–362

    Article  PubMed  CAS  Google Scholar 

  • Wolk K, Witte E, Witte K et al (2010) Biology of interleukin-22. Semin Immunopathol 32:17–31

    Article  PubMed  CAS  Google Scholar 

  • Yam KK, Pouliot P, N’diaye MM et al (2008) Innate inflammatory responses to the Gram-positive bacterium Lactococcus lactis. Vaccine 26:2689–2699

    Article  PubMed  CAS  Google Scholar 

  • Zavala-Flores LM, Villatoro-Hernandez J, Gamez-Escobedo A et al (2009) Production of biologically active human lymphotactin (XCL1) by Lactococcus lactis. Biotechnol Lett 31:215–220

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This manuscript was supported by Programa de Apoyo a la Investigación en Ciencia y Tecnología (PAICYT) from the UANL.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Odila Saucedo-Cárdenas.

Additional information

M. J. Loera-Arias and J. Villatoro-Hernández have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Loera-Arias, M.J., Villatoro-Hernández, J., Parga-Castillo, M.A. et al. Secretion of biologically active human interleukin 22 (IL-22) by Lactococcus lactis . Biotechnol Lett 36, 2489–2494 (2014). https://doi.org/10.1007/s10529-014-1626-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-014-1626-y

Keywords

Navigation